Longitudinal cytokine and transcriptomic profiling of immune-related adverse events in early-stage TNBC treated with pembrolizumab.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Cleveland Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162692983
